Abstract:Herein, we report the design and synthesis of a novel series of 6-((1 H -1,2,3-triazol-4-yl)methyl)-6 H -indolo[2,3- b ]quinoxalines ( 22–29 ) via the copper( I )-catalyzed azide–alkyne cycloaddition (CuAAC) reaction. The target compounds formed through two pathways (A and B). The structures of the newly click synthesised 1,2,3-triazole-6 H -indolo[2,3- b ]quinoxalines ( 22–29 ) were confirmed on the basis of their elemental analysis and spectral data. Some of these compounds exhibited significant antiproliferative effects against tested cancer cells, including hepatocellular carcinoma (Hep-G2), breast cancer (MCF-7), and colon cancer (HCT116), relative to healthy noncancerous control skin fibroblast cells (BJ-1) to evaluate their cytotoxic effects. Among the tested compounds, compound 27 exhibited strong activity with IC 50 = 9.3 ± 1.1, 1.5 ± 0.1, 2.4 ± 0.2, and 17.3 ± 1.2 against cancer cell lines HCT-116, HepG-2, MCF-7, and BJ-1, respectively. Therefore, compound 27 was selected for further investigation. Cell cycle analysis of liver cancer (HepG-2) cells treated with 27 showed cell cycle arrest in the S and G0/G1 phases and strong apoptotic activity, as indicated by Annexin V-FITC staining. Compound 27 was also found to fit in the ATP binding pocket during docking experiments combined with molecular dynamics simulation. Lastly, we conducted a Petra/Osiris/Molinspiration (POM) study on the synthesized compound. The most promising candidates were identified by evaluating primary in silico parameters, which showed considerable differences among individual synthesized compounds. These features can promote future drug candidate design to produce better derivatives in the search for anticancer agents, particularly those with favorable ADME parameters, low toxicity, anticipated bioactivity, and bright futures.

Synthesis of 6-Amino Acid Substituted 4,6,7,12-Tetrahydro-4-oxoindolo[2, 3-A]quinolizines

Synthesis of Enantiopure Oxoindolo-Quinolizines

Synthesis, Crystal Structure and Evaluation of Cancer Inhibitory Activity of 4-[Indol-3-yl-methylene]-1h-pyrazol-5(4h)-one Derivatives

Synthesis and Bioactivity of 6,7-Dimethoxy-quinazoline-4-arylamine Derivatives

Synthesis Andin Vitroantitumor Activities of 6,7-Dimethoxy-4-piperazinquinazoline Thiosemicarbazone Derivatives

Synthesis of 4-chloro-7-methoxy-6-pivalamidoquinazoline

Synthesis and Biological Activity of Benzo[h]quinolinium Hydrazine Compounds

Synthesis of Tumor Selective Indole and 8-Hydroxyquinoline Skeleton Containing Di-, or Triarylmethanes with Improved Cytotoxic Activity

Synthesis of 4-Chloroquinazoline Derivatives

Synthesis and in Vitro Anticancer Activity of 6,7-Methylenedioxy (or 5-Hydroxy-6-methoxy)-2-(substituted Selenophenyl)Quinolin-4-One Analogs

Synthesis and Evaluation of 4(3H) -Quinazolinone Derivatives Bearing Aromatic Amine Side Chains As Antitumor Agents

Synthesis and Antibacterial and Antitumor Properties of Derivatives of 5,5-Dimethyl-3-iso-Propyl-2-Thioxo-2,3,5,6-Tetrahydrobenzo[h]Quinazoline-4(1H)-One

Synthesis of Substituted Benzylamino‐ and Heterocyclylmethylamino Carbodithioate Derivatives of 4‐(3h)‐quinazolinone and Their Cytotoxic Activity.

Novel 5-Methyl-2-[(un)substituted Phenyl]-4-{4,5-Dihydro-3-[(Un)Substituted Phenyl]-5-(1,2,3,4-Tetrahydroisoquinoline-2-Yl)Pyrazol-1-Yl}-Oxazole Derivatives: Synthesis and Anticancer Activity

Synthesis of Antitumor 3,4,6,7-Tetrahydro-2h-pyrimido[1,6-c]quinazolin-2-imine Derivatives Via Reductive Dearomatization-Initiated Intramolecular Cyclization

Synthesis, anticancer evaluation and mechanism studies of novel indolequinone derivatives of ursolic acid

Design, synthesis, and biological evaluation of novel benzo[6,7]indolo[3,4-c]isoquinolines as anticancer agents with topoisomerase I inhibition

Synthesis and Antiproliferative Activity of 6,7-Disubstituted-4-phenoxyquinoline Derivatives Bearing the 2-Oxo-4-chloro-1,2-dihydroquinoline-3-carboxamide Moiety.

Mo-catalyzed cyclization of N -vinylindoles and skatoles: synthesis of dihydroindolo[1,2- c ]-quinazolines and dihydroindolo[3,2- b ]-indoles, and evaluation of their anticancer activities

Click synthesis of novel 6-((1 H -1,2,3-triazol-4-yl)methyl)-6 H -indolo[2,3- b ]quinoxalines for in vitro anticancer evaluation and docking studies

Synthesis of 4-Hydroxyquinolines as Potential Cytotoxic Agents